BAFF and the regulation of B cell survival (Q35174478)

6 August 2017

1 reference

title

BAFF and the regulation of B cell survival (English)

1 reference

6 August 2017

2

Jürg Tschopp

1 reference

6 August 2017

Pascal Schneider

1

1 reference

6 August 2017

1 July 2003

1 reference

6 August 2017

1 reference

6 August 2017

88

1 reference

6 August 2017

1

1 reference

6 August 2017

57-62

1 reference

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

TALL-1 is a novel member of the TNF family that is down-regulated by mitogens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Structural basis of BLyS receptor recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

APRIL modulates B and T cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

G-CSF-stimulated neutrophils are a prominent source of functional BLyS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Synthesis and release of B-lymphocyte stimulator from myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

The molecular architecture of the TNF superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

BAFF mediates survival of peripheral immature B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Regulation of the T-independent humoral response by TACI

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Activation and accumulation of B cells in TACI-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

BLyS BINDS TO B CELLS WITH HIGH AFFINITY AND INDUCES ACTIVATION OF THE TRANSCRIPTION FACTORS NF-kappaB AND ELF-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

T cell costimulation by the TNF ligand BAFF.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Two pathways to NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

CD40 regulates the processing of NF-kappaB2 p100 to p52

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900050-6

7 January 2021

10.1016/S0165-2478(03)00050-6

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12853163